Ignite Creation Date:
2024-05-06 @ 5:02 PM
Last Modification Date:
2024-10-26 @ 2:21 PM
Study NCT ID:
NCT05176080
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-05-06
First Post:
2021-11-18
Brief Title:
Famitinib Plus SHR6390 and Endocrine Therapy in the Treatment of HR-positive HER2-negative Advanced Breast Cancer
Sponsor:
Henan Cancer Hospital
Organization:
Henan Cancer Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Metastatic Breast Cancer |
Keywords: